416 related articles for article (PubMed ID: 23114842)
1. Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis.
Qiu W; Su GH
Cancer Metastasis Rev; 2013 Jun; 32(1-2):83-107. PubMed ID: 23114842
[TBL] [Abstract][Full Text] [Related]
2. Experimental animal models of pancreatic carcinogenesis and metastasis.
Wei D; Xiong HQ; Abbruzzese JL; Xie K
Int J Gastrointest Cancer; 2003; 33(1):43-60. PubMed ID: 12909737
[TBL] [Abstract][Full Text] [Related]
3. Advancements in Preclinical Models of Pancreatic Cancer.
Salu P; Reindl KM
Pancreas; 2024 Feb; 53(2):e205-e220. PubMed ID: 38206758
[TBL] [Abstract][Full Text] [Related]
4. Induction of Pancreatic Inflammation Accelerates Pancreatic Tumorigenesis in Mice.
Zhuang L; Zhan X; Bi Y; Ji B
Methods Mol Biol; 2019; 1882():287-297. PubMed ID: 30378063
[TBL] [Abstract][Full Text] [Related]
5. Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer.
Mohammed A; Janakiram NB; Madka V; Li M; Asch AS; Rao CV
Curr Med Chem; 2018; 25(22):2535-2544. PubMed ID: 28183260
[TBL] [Abstract][Full Text] [Related]
6. Development of orthotopic pancreatic tumor mouse models.
Qiu W; Su GH
Methods Mol Biol; 2013; 980():215-23. PubMed ID: 23359156
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic intraepithelial neoplasia and pancreatic tumorigenesis: of mice and men.
Ottenhof NA; Milne AN; Morsink FH; Drillenburg P; Ten Kate FJ; Maitra A; Offerhaus GJ
Arch Pathol Lab Med; 2009 Mar; 133(3):375-81. PubMed ID: 19260743
[TBL] [Abstract][Full Text] [Related]
8. Animal models for modeling pancreatic cancer and novel drug discovery.
Bisht S; Feldmann G
Expert Opin Drug Discov; 2019 Feb; 14(2):127-142. PubMed ID: 30657339
[TBL] [Abstract][Full Text] [Related]
9. A historical perspective of pancreatic cancer mouse models.
Colvin EK; Scarlett CJ
Semin Cell Dev Biol; 2014 Mar; 27():96-105. PubMed ID: 24685616
[TBL] [Abstract][Full Text] [Related]
10. Experimental animal models of pancreatic cancer (review).
Shi Q; Xie K
Int J Oncol; 2000 Aug; 17(2):217-25. PubMed ID: 10891528
[TBL] [Abstract][Full Text] [Related]
11. Mouse models of pancreatic cancer.
Herreros-Villanueva M; Hijona E; Cosme A; Bujanda L
World J Gastroenterol; 2012 Mar; 18(12):1286-94. PubMed ID: 22493542
[TBL] [Abstract][Full Text] [Related]
12. The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells.
Shin WS; Park MK; Lee YH; Kim KW; Lee H; Lee ST
Cancer Sci; 2020 Sep; 111(9):3292-3302. PubMed ID: 32644283
[TBL] [Abstract][Full Text] [Related]
13. Modeling pancreatic cancer in vivo: from xenograft and carcinogen-induced systems to genetically engineered mice.
Ding Y; Cravero JD; Adrian K; Grippo P
Pancreas; 2010 Apr; 39(3):283-92. PubMed ID: 20335777
[TBL] [Abstract][Full Text] [Related]
14. Tobacco and alcohol as risk factors for pancreatic cancer.
Korc M; Jeon CY; Edderkaoui M; Pandol SJ; Petrov MS;
Best Pract Res Clin Gastroenterol; 2017 Oct; 31(5):529-536. PubMed ID: 29195672
[TBL] [Abstract][Full Text] [Related]
15. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer.
Pasquale V; Dugnani E; Liberati D; Marra P; Citro A; Canu T; Policardi M; Valla L; Esposito A; Piemonti L
Acta Diabetol; 2019 Sep; 56(9):1013-1022. PubMed ID: 30989379
[TBL] [Abstract][Full Text] [Related]
16. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
Hruban RH; Adsay NV; Albores-Saavedra J; Anver MR; Biankin AV; Boivin GP; Furth EE; Furukawa T; Klein A; Klimstra DS; Kloppel G; Lauwers GY; Longnecker DS; Luttges J; Maitra A; Offerhaus GJ; Pérez-Gallego L; Redston M; Tuveson DA
Cancer Res; 2006 Jan; 66(1):95-106. PubMed ID: 16397221
[TBL] [Abstract][Full Text] [Related]
17. Clinically-relevent orthotopic metastatic models of pancreatic cancer imageable with fluorescent genetic reporters.
Bouvet M; Hoffman RM
Minerva Chir; 2009 Oct; 64(5):521-39. PubMed ID: 19859041
[TBL] [Abstract][Full Text] [Related]
18. A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies.
de Latouliere L; Manni I; Iacobini C; Pugliese G; Grazi GL; Perri P; Cappello P; Novelli F; Menini S; Piaggio G
Ann Anat; 2016 Sep; 207():2-8. PubMed ID: 26704357
[TBL] [Abstract][Full Text] [Related]
19. Genetically engineered mouse models of pancreatic cancer.
Westphalen CB; Olive KP
Cancer J; 2012; 18(6):502-10. PubMed ID: 23187836
[TBL] [Abstract][Full Text] [Related]
20. Recent developments of transgenic and xenograft mouse models of pancreatic cancer for translational research.
Schütte U; Bisht S; Brossart P; Feldmann G
Expert Opin Drug Discov; 2011 Jan; 6(1):33-48. PubMed ID: 22646825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
